价格

HDAC6

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

INHIBITING HISTONE DEACETYLASE 6 (HDAC6)
EP 4504191 A4申请人: EIKONIZO THERAPEUTICS INC优先权: 2022
CN
EP
US
WO
11 件公开
2-ISOINDOL-1,3,4-OXADIAZOLE DERIVATIVES USEFUL AS HDAC6 INHIBITORS
EP 4034536 A1申请人: TAKEDA PHARMACEUTICALS CO优先权: 2019
CN
EP
US
WO
8 件公开
3-(2-(HETEROARYL)-PYRIDIN-4-YL)-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLE DERIVATIVES AS HDAC6 INHIBITORS
EP 3980416 B1申请人: ORYZON GENOMICS SA优先权: 2019
CN
EP
US
WO
6 件公开
HDAC6 INHIBITORS AND USES THEREOF
- EP 4003319 A4
  申请人: EIKONIZO THERAPEUTICS INC优先权: 2019
  CN
  EP
  US
  WO
  6 件公开
- US 2024174616 A1
  申请人: EIKONIZO THERAPEUTICS INC优先权: 2021
  US
  WO
  3 件公开
- US 9586973 B2
  申请人: UNIV GENT优先权: 2015
  US
- US 20250179065 A1
  申请人: EIKONIZO THERAPEUTICS INC优先权: 2023
  US
HDAC6 INHIBITORS AND IMAGING AGENTS
EP 4397656 A2申请人: MASSACHUSETTS GEN HOSPITAL优先权: 2017
CN
EP
US
6 件公开
QUINAZOLINE DERIVATIVES USEFUL AS SELECTIVE HDAC6 INHIBITORS
EP 4161908 A1申请人: ANNJI PHARM CO LTD优先权: 2020
CN
EP
US
WO
4 件公开
NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS
US 2023286970 A1申请人: ITALFARMACO SPA优先权: 2020
CN
EP
US
WO
4 件公开
A COMBINATION COMPRISING A SPECIFIC HDAC6 INHIBITOR AND AT LEAST ONE CTLA4 CHECKPOINT INHIBITOR
EP 4326259 A1申请人: ITALFARMACO SPA优先权: 2021
CN
EP
US
WO
4 件公开
DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORS
EP 4568949 A1申请人: ITALFARMACO SPA优先权: 2022
CN
EP
US
WO
4 件公开
HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS
EP 4680602 A1申请人: MIRALINC PHARMA INC优先权: 2023
CN
EP
US
WO
4 件公开

药物

HDAC6

专利

HDAC6 INHIBITORS AND USES THEREOF